Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated)
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Name
- Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated)
- Accession Number
- DB10584
- Description
- Not Available
- Type
- Biotech
- Groups
- Approved, Investigational
- Biologic Classification
- Vaccines
Inactivated - Synonyms
- Diphtheria toxoid
- Diphtheria toxoid adsorbed
Pharmacology
- Indication
- Not Available
- Associated Conditions
- Contraindications & Blackbox Warnings
Learn about our commercial Contraindications & Blackbox Warnings data.
Learn More- Pharmacodynamics
- Not Available
- Mechanism of action
- Not Available
- Absorption
- Not Available
- Volume of distribution
- Not Available
- Protein binding
- Not Available
- Metabolism
- Not Available
- Route of elimination
- Not Available
- Half-life
- Not Available
- Clearance
- Not Available
- Adverse Effects
Learn about our commercial Adverse Effects data.
Learn More- Toxicity
- Not Available
- Affected organisms
- Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Drug Interaction Unlock Additional DataAbatacept The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Abatacept. Adalimumab The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Adalimumab. Aldesleukin The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Aldesleukin. Alefacept The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Alefacept. Alemtuzumab The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Alemtuzumab. Altretamine The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Altretamine. Amsacrine The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Amsacrine. Anakinra The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Anakinra. Antilymphocyte immunoglobulin (horse) The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Antilymphocyte immunoglobulin (horse). Antithymocyte immunoglobulin (rabbit) The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Antithymocyte immunoglobulin (rabbit). Additional Data Available- Extended DescriptionExtended DescriptionAvailable for Purchase
Extended description of the mechanism of action and particular properties of each drug interaction.
Learn more - SeveritySeverityAvailable for Purchase
A severity rating for each drug interaction, from minor to major.
Learn more - Evidence LevelEvidence LevelAvailable for Purchase
A rating for the strength of the evidence supporting each drug interaction.
Learn more - ActionActionAvailable for Purchase
An effect category for each drug interaction. Know how this interaction affects the subject drug.
Learn more
- Food Interactions
- Not Available
Products
- Brand Name Prescription Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Unlock Additional DataDiphtheria Toxoid Liquid Subcutaneous Aventis Pasteur Limited 1925-12-31 2001-07-19 Canada 
Diphtheria Toxoid for Reaction Test 0.2lf/ml Liquid Intradermal Aventis Pasteur Limited 1955-01-01 2000-04-06 Canada Diphtheria Toxoid for Schick Control 0.2lf/ml Liquid Intradermal Connaught Laboratories Ltd. 1925-12-31 1996-09-10 Canada Diphtheria Toxoid Immunization Of Reactors Liquid Subcutaneous Aventis Pasteur Limited 1933-12-31 2001-07-19 Canada Additional Data Available- Application NumberApplication NumberAvailable for Purchase
A unique ID assigned by the FDA when a product is submitted for approval by the labeller.
Learn more - Product CodeProduct CodeAvailable for Purchase
A governmentally-recognized ID which uniquely identifies the product within its regulatory market.
Learn more
- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Adacel TDaP Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (2 [Lf]/0.5mL) + Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) (5 ug/0.5mL) + Bordetella pertussis fimbriae 2/3 antigen (5 ug/0.5mL) + Bordetella pertussis pertactin antigen (3 ug/0.5mL) + Bordetella pertussis toxoid antigen (glutaraldehyde inactivated) (2.5 ug/0.5mL) + Clostridium tetani toxoid antigen (formaldehyde inactivated) (5 [Lf]/0.5mL) Injection, suspension Intramuscular Sanofi Pasteur Inc. 2005-06-10 Not applicable US 
Adacel TDaP TDaP Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (2 [Lf]/0.5mL) + Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) (5 ug/0.5mL) + Bordetella pertussis fimbriae 2/3 antigen (5 ug/0.5mL) + Bordetella pertussis pertactin antigen (3 ug/0.5mL) + Bordetella pertussis toxoid antigen (glutaraldehyde inactivated) (2.5 ug/0.5mL) + Clostridium tetani toxoid antigen (formaldehyde inactivated) (5 [Lf]/0.5mL) Injection, suspension Intramuscular Remedy Repack 2015-11-14 2016-03-29 US Boostrix Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (2.5 [iU]/0.5mL) + Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) (8 ug/0.5mL) + Bordetella pertussis pertactin antigen (formaldehyde inactivated) (2.5 ug/0.5mL) + Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) (8 ug/0.5mL) + Clostridium tetani toxoid antigen (formaldehyde inactivated) (5 [iU]/0.5mL) Suspension Intramuscular A-S Medication Solutions 2009-07-24 Not applicable US Boostrix Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (2.5 [iU]/0.5mL) + Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) (8 ug/0.5mL) + Bordetella pertussis pertactin antigen (formaldehyde inactivated) (2.5 ug/0.5mL) + Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) (8 ug/0.5mL) + Clostridium tetani toxoid antigen (formaldehyde inactivated) (5 [iU]/0.5mL) Suspension Intramuscular GlaxoSmithKline Biologicals SA 2009-07-24 Not applicable US Boostrix Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (2.5 [iU]/0.5mL) + Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) (8 ug/0.5mL) + Bordetella pertussis pertactin antigen (formaldehyde inactivated) (2.5 ug/0.5mL) + Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) (8 ug/0.5mL) + Clostridium tetani toxoid antigen (formaldehyde inactivated) (5 [iU]/0.5mL) Suspension Intramuscular A-S Medication Solutions 2009-07-24 Not applicable US CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS TOXOID ANTIGEN (GLUTARALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS PERTACTIN ANTIGEN, and BORDETELLA PERTUSSIS FIMBRIAE 2/3 ANTIGEN Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (2 [Lf]/0.5mL) + Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) (5 ug/0.5mL) + Bordetella pertussis fimbriae 2/3 antigen (5 ug/0.5mL) + Bordetella pertussis pertactin antigen (3 ug/0.5mL) + Bordetella pertussis toxoid antigen (glutaraldehyde inactivated) (2.5 ug/0.5mL) + Clostridium tetani toxoid antigen (formaldehyde inactivated) (5 [Lf]/0.5mL) Injection, suspension Intramuscular A-S Medication Solutions 2005-06-10 Not applicable US D2t5 Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (2 lf) + Clostridium tetani toxoid antigen (formaldehyde inactivated) (5 lf) Suspension Intramuscular ID Biomedical Corporation of Quebec 1991-12-31 2005-08-03 Canada Daptacel Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (15 [Lf]/0.5mL) + Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) (5 ug/0.5mL) + Bordetella pertussis fimbriae 2/3 antigen (5 ug/0.5mL) + Bordetella pertussis pertactin antigen (3 ug/0.5mL) + Bordetella pertussis toxoid antigen (glutaraldehyde inactivated) (10 ug/0.5mL) + Clostridium tetani toxoid antigen (formaldehyde inactivated) (5 [Lf]/0.5mL) Injection, suspension Intramuscular Sanofi Pasteur Inc. 2002-05-14 Not applicable US Decavac Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (2 [Lf]/0.5mL) + Clostridium tetani toxoid antigen (formaldehyde inactivated) (5 [Lf]/0.5mL) Suspension Intramuscular Sanofi Pasteur Limited 2004-03-24 2016-05-19 US Diphtheria and Tetanus Toxoids Adsorbed Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (6.7 [Lf]/0.5mL) + Clostridium tetani toxoid antigen (formaldehyde inactivated) (5 [Lf]/0.5mL) Injection, suspension Intramuscular Sanofi Pasteur Limited 1984-09-18 2013-03-18 US
Categories
- ATC Codes
- J07AF01 — Diphtheria toxoid
- Drug Categories
- Classification
- Not classified
Chemical Identifiers
- UNII
- IRH51QN26H
- CAS number
- 308079-75-6
References
- General References
- Not Available
- External Links
- AHFS Codes
- 36:28.00 — Diphtheria
- 80:08.00 — Toxoids
Clinical Trials
- Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Injection, solution Intramuscular 2 Lf/0.5mL Injection, suspension Intramuscular 2 Lf/0.5mL Injection, suspension Intramuscular 5 ug/0.5mL Injection Intramuscular 40 Lf Injection, suspension Intramuscular 56 iu/1mL Injection, suspension Intramuscular 8 ug/0.5mL Suspension Intramuscular 2 IU/0.5ml Injection, suspension Intramuscular 8 mcg/0.5ml Injection, suspension Intramuscular 2.5 mcg Suspension Intramuscular 8 cg Injection, suspension Intramuscular 5 iu/0.5mL Injection, suspension 30 iu/0.5mL Suspension Intramuscular Injection Intramuscular 20 UI Injection, suspension Intramuscular Liquid Intramuscular Liquid Subcutaneous Liquid Intradermal Injection, suspension Parenteral 6.25 Lf Injection, suspension Parenteral 2 IU Injection, suspension Parenteral 20 mcg Injection, suspension Intramuscular 4 IU/0.5ml Injection, suspension Intramuscular 20 UI Injection, solution Intramuscular 20 IU Injection, suspension Intramuscular 25 mcg/0.5ml Suspension Intramuscular 2 IU Injection, suspension Intramuscular 25 ug/0.5mL Injection, powder, for suspension Intramuscular 25 mcg Injection, powder, for suspension Intramuscular 30 UI Suspension Intramuscular 30 UI Injection, powder, for suspension Intramuscular 10 mcg Injection, powder, for suspension Intramuscular 25 mcg/0.5ml Injection, powder, for suspension Intramuscular 8 μg Injection, suspension Intramuscular 40 [D'ag'U]/0.5mL Solution Intramuscular 4 mcg Injection Intramuscular 30 IU Injection, powder, for suspension Intramuscular 30 IU/0.5ml Injection, suspension Intramuscular 2 IU Injection, suspension Intramuscular 20 IU/0.5ml Injection, suspension Intramuscular 2 UI Injection, suspension Intramuscular 40 IU/0.5mL Injection, suspension Intramuscular 2 iu/0.5mL Injection Intramuscular 40 IU Injection, solution Intramuscular 40 IU/0.5mL Injection, suspension Intramuscular 30 UI Injection, suspension Intramuscular 30 IU Injection, suspension Intramuscular 30 IU/0.5mL Injection, suspension Intramuscular; Subcutaneous 2 IU/0.5ml Injection Intramuscular - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created on December 01, 2015 13:04 / Updated on January 23, 2021 21:03